2023 Guidelines on the Diagnosis and Treatment of Insomnia in Adults - Brazilian Sleep Association
Open accessThe DOI matches its Crossref record; 266 of the 268 references it cites were found in a registry or an index.
Abstract
Chronic insomnia disorder (simplified in this document as insomnia) is an increasingly common clinical condition in society and a frequent complaint at the offices of different areas of health practice (particularly Medicine and Psychology). This scenario has been accompanied by a significant evolution in treatment, as well as challenges in approaching patients in an appropriately way. This clinical guideline, coordinated by the Brazilian Sleep Association and the Brazilian Association of Sleep Medicine and counting on the active participation of various specialists in the area, encompasses an update on the diagnosis and treatment of insomnia in adults. To this end, it followed a structured methodology. Topics of interest related to diagnosis were written based on theoretical framework, evidence in the literature, and professional experience. As for the topics related to the treatment of insomnia, a series of questions were developed based on the PICO acronym (P – Patient, problem, or population; I – Intervention; C – Comparison, control, or comparator; O – Outcome). The work groups defined the eligible options within each of these parameters. Regarding pharmacological interventions, only the ones currently available in Brazil or possibly becoming available in the upcoming years were considered eligible. Systematic reviews were conducted to help prepare the texts and define the level of evidence for each intervention. The final result is an objective and practical document providing recommendations with the best scientific support available to professionals involved in the management of insomnia.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures



Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“With increased Z-drug use, a range of serious adverse effects has been identified, including delirium, sleep-related eating disorder, amnesia, and complex behaviors such as sleep-driving; these effects may occur at therapeutic doses, and they are intensified by alcohol or other sedatives.”
From Z-drug abuse and dependence: Clinical guideline of the Brazilian Academy of Neurology for diagnosis and management (2025) · cites this paper as [6]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“In contrast, eszopiclone has demonstrated safety for up to 12 months in primary insomnia patients.”
From Z-drug abuse and dependence: Clinical guideline of the Brazilian Academy of Neurology for diagnosis and management (2025) · cites this paper as [6]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–266 of 266
Uchiyama, M., Hamamura, M., Kuwano, T., Nishiyama, H., Nagata, H., & Uchimura, N. (2011) · Sleep Medicine · doi:10.1016/j.sleep.2010.08.010 · Cited by 44
Eszopiclone versus zopiclone in the treatment of insomnia
Pinto, L. R., Bittencourt, L., Treptow, E. C., Braga, L. R., & Tufik, S. (2016) · Clinics · doi:10.6061/clinics/2016(01)02 · Cited by 44
Baron, P., Hermand, É., Bourlois, V., Pezé, T., Aron, C., Lombard, R., & Hurdiel, R. (2023) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph20085452 · Cited by 44
Severe Chronic Abuse of Zolpidem in Refractory Insomnia
Chiaro, G., Castelnovo, A., Bianco, G., Maffei, P., & Manconi, M. (2018) · Journal of Clinical Sleep Medicine · doi:10.5664/jcsm.7240 · Cited by 43 · cited 1×
“137 In Brazil, between 2018 and 2022, there was a 161% growth in zolpidem sales, reaching, almost 22 million boxes sold in 2022, according to data provided by the National Controlled Products Management System, managed by the National Health Surveillance Agency (ANVISA).”
MethodZhang, Y., Ren, R., Yang, L., Zhang, H., Shi, Y., Shi, J., Sanford, L. D., Lu, L., Vitiello, M. V., & Tang, X. (2022) · Sleep Medicine Reviews · doi:10.1016/j.smrv.2022.101687 · Cited by 43
Efficacy of Melatonin for Insomnia in Children with Autism Spectrum Disorder: A Meta-analysis
Xiong, M., Li, F., Liu, Z., Xie, X., Shen, H., Li, W., Wei, L., & He, R. (2023) · Neuropediatrics · doi:10.1055/s-0043-1761437 · Cited by 43
Kennett, L., Bei, B., & Jackson, M. L. (2021) · Mindfulness · doi:10.1007/s12671-021-01714-5 · Cited by 42 · cited 2×
“127”
Kryger, M., Wang-Weigand, S., Zhang, J., & Roth, T. (2008) · Sleep and Breathing · doi:10.1007/s11325-007-0156-4 · Cited by 41 · cited 4×
“Other considerations: 1) Toxicityand relatively lowabuse potential compared with other hypnotic agents 199 ; 2) Evidence of safety with more prolonged use and no evidence of rebound insomnia in 12-month-use studies 189 ; 3) Safety in older patients and patients with comorbidities such as chronic obstructive pulmonary…”
BackgroundInfluentialFrange, C., Franco, A. M., Brasil, E. L., Hirata, R. P., Lino, J. A., Mortari, D. M., Ykeda, D. S., Leocádio-Miguel, M. A., D’Aurea, C. V. R., Silva, L. O. E., et al. (2022) · Sleep Science · doi:10.5935/1984-0063.20220083 · Cited by 41
Self-citationEdemann-Callesen, H., Andersen, H. K., Ussing, A., Virring, A., Jennum, P., Debes, N. M., Laursen, T., Baandrup, L., Gade, C., Nielsen, J. D., et al. (2023) · EClinicalMedicine · doi:10.1016/j.eclinm.2023.102048 · Cited by 41 · cited 1×
“213,214 There is evidence suggesting that melatonin can effectively treat chronic insomnia in children with neurological diseases, especially autism and attention-de fi cit/hyperactivity disorder (ADHD), as well as older adults.”
BackgroundMadruga, C. S., Paim, T. L., Palhares, H. N., Miguel, A. C., Massaro, L. T. S., Caetano, R., & Laranjeira, R. R. (2019) · Brazilian Journal of Psychiatry · doi:10.1590/1516-4446-2018-0088 · Cited by 40
Acupuncture for Primary Insomnia: An Updated Systematic Review of Randomized Controlled Trials
Cao, H., Yu, M., Wang, Y., Fei, Y., Xu, H., & Liu, J. (2019) · The Journal of Alternative and Complementary Medicine · doi:10.1089/acm.2018.0046 · Cited by 40 · cited 3×
“107 Therapeutic planning: Only in cases of insomnia comorbid with diseases of which BZDs are treatment options (e.g., epilepsy, some psychiatric and sleep disorders) is it possible to seek their therapeutic hypnotic effect according to the clinical standard.”
BackgroundKim, S.-H., Jeong, J.-H., Lim, J.-H., & Kim, B.-K. (2019) · Integrative Medicine Research · doi:10.1016/j.imr.2019.08.002 · Cited by 40
Drager, L. F., Pachito, D. V., Moreno, C. R. D. C., Júnior, A. R. T., Conway, S. G., Assis, M., Sguillar, D. A., Moreira, G. A., Bacelar, A., & Genta, P. R. (2021) · Journal of Clinical Sleep Medicine · doi:10.5664/jcsm.9570 · Cited by 40
Self-citationMiller, C. B., Espie, C. A., Bartlett, D. J., Marshall, N. S., Gordon, C. J., & Grunstein, R. R. (2018) · Scientific Reports · doi:10.1038/s41598-018-25033-3 · Cited by 39
Painful Sleep: Insomnia in Patients with Chronic Pain Syndrome and its Consequences
Ostovar-Kermani, T. G., Arnaud, D., Almaguer, A., Garcia, I., Gonzalez, S., Mendez, Y. H., & Surani, S. (2020) · Folia Medica · doi:10.3897/folmed.62.e50705 · Cited by 39 · cited 1×
“12,40 – 42 Apossibleexplanationforsuchariskisthatchronic insomniachangesthelevelsofin fl ammatorymediators.”
Herring, W. J., Connor, K. M., Snyder, E., Snavely, D. B., Morin, C. M., Lines, C., & Michelson, D. (2018) · Sleep Medicine · doi:10.1016/j.sleep.2018.09.010 · Cited by 38
Khazaie, H., Sadeghi, M., Khazaie, S., Hirshkowitz, M., & Sharafkhaneh, A. (2022) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2022.1070522 · Cited by 38
Long-term safety and efficacy of ramelteon in Japanese patients with chronic insomnia.
Uchiyama, M., Hamamura, M., Kuwano, T., Nagata, H., Hashimoto, T., Ogawa, A., & Uchimura, N. (2011) · Sleep Medicine · doi:10.1016/j.sleep.2010.10.006 · Cited by 37
Lou, B. X., & Oks, M. (2021) · Clinics in Geriatric Medicine · doi:10.1016/j.cger.2021.04.003 · Cited by 37 · cited 3×
“222,223 Therapeutic planning : The recommended initial dose is 3mg used (cid:1) 30minutes before the planned sleep onset time.”
BackgroundMethodXiang, T., Cai, Y., Hong, Z., & Pan, J. (2021) · Sleep Medicine · doi:10.1016/j.sleep.2021.09.005 · Cited by 37
Kohsaka, M., Kanemura, T., Taniguchi, M., Kuwahara, H., Mikami, A., Kamikawa, K., Uno, H., Ogawa, A., Murasaki, M., & Sugita, Y. (2011) · Expert Review of Neurotherapeutics · doi:10.1586/ern.11.128 · Cited by 36
Chan, N. Y., Lam, S. P., Zhang, J., Chan, J. W. Y., Yu, M. M. W., Suh, S. A., Yang, C., Okajima, I., Li, A. M., Wing, Y. K., et al. (2022) · Journal of Adolescent Health · doi:10.1016/j.jadohealth.2021.11.005 · Cited by 36
He, D., Guo, Z., McClure, M. A., Mu, Q., & Jiang, B. (2022) · Sleep Medicine Reviews · doi:10.1016/j.smrv.2022.101736 · Cited by 36 · cited 1×
“78,79”
Mini, L., Wang-Weigand, S., & Zhang, J. (2008) · Clinical Therapeutics · doi:10.1016/s0149-2918(08)80056-2 · Cited by 35
Tsutsui, S., & Zolpidem Study Group (2001) · Journal of International Medical Research · doi:10.1177/147323000102900303 · Cited by 35 · cited 1×
“Eszopiclone was associated with signi fi cant improvements in subjective sleep latency, WASO, number of wakes, TST, increasing sleep quality, ability to function, daytime alertness, and sense of physical well-being in studies with follow-ups of 1 week, 2 weeks, 1 month, 3 months, and 6 months.”
BackgroundInsomnia treatment response as a function of objectively measured sleep duration
Rochefort, A., Jarrin, D. C., Bélanger, L., Ivers, H., & Morin, C. M. (2019) · Sleep Medicine · doi:10.1016/j.sleep.2019.01.016 · Cited by 35
Bradford, D. R. R., Biello, S. M., & Russell, K. (2021) · Chronobiology International · doi:10.1080/07420528.2021.1931274 · Cited by 35 · cited 1×
“56,57 This chapter aims to recommend the approaches with the highest level of scienti fi c evidence for clinical outcomes and follow-up, considering objective parameters assessed with PSG and actigraphy and subjective ones obtained from sleep diaries and questionnaires that assess the severity of…”
Forma, F. M., Pratiwadi, R., Moustaid, F. E., Smith, N., Thorndike, F. P., & Velez, F. F. (2022) · Current Medical Research and Opinion · doi:10.1080/03007995.2022.2108616 · Cited by 35 · cited 1×
“50,64,83 These effects are long-lasting and independent of comorbidity, age, and sex, 49,64,92 especially in the presence of clinical support during follow-up.”
BackgroundYang, M. A., Yang, J., Gong, M., Luo, R., Lin, Q., & Wang, B. (2023) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph20043074 · Cited by 35
Benzodiazepine use in Sao Paulo, Brazil
Campanha, A. M., Salto, A. B. R., Milhorança, I. A., Bernik, M., Viana, M. C., Wang, Y., & Andrade, L. H. (2020) · Clinics · doi:10.6061/clinics/2020/e1610 · Cited by 34
D’Aurea, C. V. R., Frange, C., Poyares, D., Souza, A. A. L. D., & Lenza, M. (2022) · Einstein (São Paulo) · doi:10.31744/einstein_journal/2022ao8058 · Cited by 33 · cited 1×
“127”
Self-citationKrieger, T., Urech, A., Duss, S. B., Blättler, L., Schmitt, W., Gast, H., Bassetti, C., & Berger, T. (2019) · Sleep Medicine · doi:10.1016/j.sleep.2019.01.045 · Cited by 33
Biofeedback Therapies for Chronic Insomnia: A Systematic Review
de Melo, D. L. M., de Carvalho, L. B. C., do Prado, L. B. F., & do Prado, G. F. (2019) · Applied Psychophysiology and Biofeedback · doi:10.1007/s10484-019-09442-2 · Cited by 33
Liang, L., Huang, Y., Xu, R., Wei, Y., Xiao, L., & Wang, G. (2019) · Sleep Medicine · doi:10.1016/j.sleep.2019.03.016 · Cited by 32
Luik, A. I., Marsden, A., Emsley, R., Henry, A. L., Stott, R. B., Miller, C. B., & Espie, C. A. (2020) · Journal of Sleep Research · doi:10.1111/jsr.13018 · Cited by 32
Uchimura, N., Ogawa, A., Hamamura, M., Hashimoto, T., Nagata, H., & Uchiyama, M. (2011) · Expert Review of Neurotherapeutics · doi:10.1586/ern.10.197 · Cited by 30
Meta-analysis of clozapine and insomnia in schizophrenia
Miller, B. J., McEvoy, J. P., & McCall, W. V. (2023) · Schizophrenia Research · doi:10.1016/j.schres.2023.01.018 · Cited by 29 · cited 3×
“19,20,247 Considering atypical antipsychotics, a 2023 meta-analysis evaluated eight controlled RCTs on the impact of the use of this class of sleep drugs during the treatment of schizophrenia.”
BackgroundInfluentialEffects of valerian extract on the sleep-wake cycle in sleep-disturbed rats.
Shinomiya, K., Fujimura, K., Kim, Y., & Kamei, C. (2005) · PubMed · doi:10.18926/amo/31980 · Cited by 28
Pharmacokinetic evaluation of eszopiclone: clinical and therapeutic implications
Greenblatt, D. J., & Zammit, G. K. (2012) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425255.2012.741588 · Cited by 28
Khalsa, S. B. S., & Goldstein, M. R. (2021) · Journal of Clinical Sleep Medicine · doi:10.5664/jcsm.9320 · Cited by 28
Neurofeedback for insomnia: Current state of research
Lambert-Beaudet, F., Journault, W.-G., Provençal, A. R., & Bastien, C. (2021) · World Journal of Psychiatry · doi:10.5498/wjp.v11.i10.897 · Cited by 28
Telemedicine and insomnia: a comprehensive systematic review and meta-analysis
Sharafkhaneh, A., Salari, N., Khazaie, S., Ghasemi, H., Darvishi, N., Hosseinian-Far, A., Mohammadi, M., & Khazaie, H. (2022) · Sleep Medicine · doi:10.1016/j.sleep.2022.01.016 · Cited by 26 · cited 2×
“63,82,85,86 Online and digital CBT-I services compared with control conditions demonstrate improvement in subjective sleep parameters.”
BackgroundKwan, Y., Yoon, S.-Y., Suh, S. A., & Choi, S. (2022) · Applied Psychophysiology and Biofeedback · doi:10.1007/s10484-022-09534-6 · Cited by 26 · cited 1×
“105 A recent randomized study by Kwan and colleagues 106 suggested that a neurofeed-back protocol was comparable in ef fi cacy to CBT-I, but the small sample size precludes any conclusions in this regard.”
BackgroundRoth, T. G., Rosenberg, R. P., Morin, C. M., Yardley, J., Pinner, K., Perdomo, C. A., Atkins, N., Pappadopulos, E. A., Malhotra, M., & Moline, M. L. (2022) · Sleep Medicine · doi:10.1016/j.sleep.2022.01.024 · Cited by 25 · cited 1×
“178 There is no evidence of rebound insomnia or withdrawal after stopping 12 months of treatment.”
BackgroundLucena, L. D. R., Santos-Junior, J. G., Tufik, S., & Hachul, H. (2023) · EXPLORE · doi:10.1016/j.explore.2023.07.004 · Cited by 25
Efficacy and Safety of Scalp Acupuncture for Insomnia: A Systematic Review and Meta-Analysis
Liu, F.-G., Tan, A.-H., Peng, C.-Q., Tan, Y.-X., & Yao, M.-C. (2021) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2021/6621993 · Cited by 20
Ruan, J., Chen, S., Liang, J., Mak, Y. W., Yee Ho, F. Y., Chung, K. F., Kwun Tong, A. K., Zhang, X. L., & Yeung, W. F. (2022) · Journal of Contextual Behavioral Science · doi:10.1016/j.jcbs.2022.09.002 · Cited by 20 · cited 11×
“83 Compared with a waiting list and a psychoeducation con-trol group, ACT reduced the severity of insomnia 55,68 and improved sleep parameters and secondary outcomes such as dysfunctional beliefs and attitudes about sleep, acceptance of sleep problems, daytime sleepiness, and cognitive suppression.”
BackgroundMethodInfluentialJiang, F., Li, H., Chen, Y., Lu, H., Ni, J., & Chen, G. (2023) · Medicine · doi:10.1097/md.0000000000032754 · Cited by 20
Uchimura, N., Kamijo, A., Kuwahara, H., Uchiyama, M., Shimizu, T., Chiba, S., & Inoue, Y. (2012) · Sleep Medicine · doi:10.1016/j.sleep.2012.08.015 · Cited by 19
Treatment of Benzodiazepine Dependence.
Soyka, M. (2017) · PubMed · doi:10.1056/nejmc1705239 · Cited by 19
Sublingual and oral zolpidem for insomnia disorder: a 3-month randomized trial
Castro, L. D. S., Otuyama, L. J., dos Santos, C. F., Tufik, S., & Poyares, D. R. (2019) · Brazilian Journal of Psychiatry · doi:10.1590/1516-4446-2019-0389 · Cited by 19 · cited 1×
“128,131,132,135 The risk of falls and fractures is increased, especially among older people.”
BackgroundSelf-citationWang-Weigand, S., Watissée, M., & Roth, T. (2011) · Sleep Medicine · doi:10.1016/j.sleep.2011.06.008 · Cited by 18
Diagnóstico diferencial del insomnio con otros trastornos primarios del sueño comórbidos
Ferré, À., Rodriguez-Ulecia, I., & García-Gurtubay, I. (2020) · Atención Primaria · doi:10.1016/j.aprim.2019.11.011 · Cited by 18
The efficacy of biofeedback for the treatment of insomnia: a critical review
Lovato, N., Miller, C. B., Gordon, C. J., Grunstein, R. R., & Lack, L. C. (2018) · Sleep Medicine · doi:10.1016/j.sleep.2018.12.011 · Cited by 16
Staner, C., Joly, F., Jacquot, N., Vlasova, I. D., Nehlin, M., Lundqvist, T., Edenius, C., & Staner, L. (2010) · Current Medical Research and Opinion · doi:10.1185/03007991003788225 · Cited by 15 · cited 1×
“128,131,132,135 The risk of falls and fractures is increased, especially among older people.”
BackgroundZhang, X., Wang, X., Le, S., Ojanen, X., Tan, X. W., Wiklund, P., & Cheng, S. (2020) · Sports Medicine and Health Science · doi:10.1016/j.smhs.2020.05.002 · Cited by 15 · cited 4×
“117 Both physical exercise and diet improved sleep quality and reduced objective sleep latency and sleep ef fi ciency in relation to the baseline period.”
BackgroundInfluentialFang, Q., Wang, X., Liu, C., Xi, H., Wan, Q., Qin, S., Xu, L., Tian, Q., Pan, R., & Wu, W. (2021) · The Anatomical Record · doi:10.1002/ar.24745 · Cited by 13
Efficacy and safety of lemborexant over 12 months in Asian adults with insomnia disorder
Dash, A., Pinner, K., Inoue, Y., Hayashida, K., Lim, S. C., Yun, C., Lan, T., Huang, C.-L., Yardley, J., Kubota, N., et al. (2022) · Sleep Medicine X · doi:10.1016/j.sleepx.2022.100044 · Cited by 12
Designer Benzodiazepines: Effects, Toxicity, and Interactions
Balkhi, S. E., & Abbara, C. (2023) · Therapeutic Drug Monitoring · doi:10.1097/ftd.0000000000001071 · Cited by 12 · cited 1×
“Therapeutic planning: According to the American Food and Drug Administration (FDA), the recommended dose is 10 mg taken once at night, 30minutes before going to bed, and at least 7hours before the planned time to get up the next morning.”
BackgroundBiofeedback as an Adjunct or Alternative Intervention to Cognitive Behavioral Therapy for Insomnia
Kremer, S., & Blue, T. (2023) · Sleep Medicine Clinics · doi:10.1016/j.jsmc.2022.10.003 · Cited by 12
Yu, H., Zhang, Y., Liu, Q., & Yan, R. (2021) · Annals of Palliative Medicine · doi:10.21037/apm-21-2387 · Cited by 10
de Entrambasaguas, M., Díaz‐Silveira, C., Burgos-Julián, F. A., & Germán, M. Á. S. (2023) · Clinical Psychology & Psychotherapy · doi:10.1002/cpp.2874 · Cited by 9 · cited 1×
“Studies involving mindfulness-based intervention protocols compared with controls demonstrate improvements in ISI, 56,95 – 97 PSQI, 97 – 99 and subjective sleep parameters: sleep latency, sleep ef fi ciency, WASO, 97,98 with improvement in mental health parameters during follow-up.”
MethodSintomas de insônia durante a pandemia de covid-19: um estudo caso-controle
Bacelar, A., Conway, S. G., Assis, M., Cardoso, V. M., Genta, P. R., Pachito, D. V., Júnior, A. R. T., Sguillar, D. A., Moreira, G. A., Drager, L. F., et al. (2023) · Revista de Saúde Pública · doi:10.11606/s1518-8787.2023057004801 · Cited by 7
Self-citationInsomnia disorder update: the benefits of screening and treatment for this common presentation
Ree, M. J., & Richardson, C. E. (2021) · Internal Medicine Journal · doi:10.1111/imj.15567 · Cited by 5 · cited 1×
“They mostly explain or approach more in-depth factors involved in the etiology of insomnia described by Spielman and colleagues in the 3P model.”
BackgroundJi, H., Zhang, K., Lu, Y., Kong, X., & Ma, X. (2022) · Medicine · doi:10.1097/md.0000000000031515 · Cited by 3
Research works printed but not linked: 8
- AASM International Classification of Sleep Disorders Darien, IL American Academy of Sleep Medicine 2014
- Leeflang M M Davenport C Bossuyt P Chapter 6: Defining the review question. Draft version (14 January 2022) 2 ed. London Cochrane 2022
- Perlis M Aloia M Kuhn BBehavioral treatments for sleep disorders: A comprehensive primer of behavioral sleep medicine intervention: Academic Press; 2010
- Hayes S C Strosahl K D Wilson K G Acceptance and commitment therapy: An experiential approach to behaviour change New York The Guiford Press 1999
- Kabat-Zinn J Catastrophe Living: Using the Wisdom of your Body and Mind to Face Stress, Pain, and Illness New York Delacorte Press 1990
- Seyffert M Lagisetty P Landgraf J Internet-Delivered Cognitive Behavioral Therapy to Treat Insomnia: A Systematic Review and Meta-Analysis PLoS One 2016 11 02 e0149139 26867139 PMC4750912 · DOI · Paper page
- Bacelar A Pinto L R Jr Insônia - Do diagnóstico ao tratamento São Caetano do Sul 2019172 p.
- A review of the pharmacological and clinical profile of mirtazapine [press release] US Neva Press 2001
Cited by
Pires, G. N., Arnardóttir, E. S., Bailly, S., & McNicholas, W. T. (2024) · Journal of Sleep Research · doi:10.1111/jsr.14163 · Cited by 12
“Since then, this method has been extensively utilized, including in sleep medicine (Berezin et al., 2021; Boerner et al., 2015; Drager et al., 2023; Murphie et al., 2018; Pearson et al., 2020; Studart-Pereira et al., 2023).”
Self-citationInsomnia and its treatments—trend analysis and publication profile of randomized clinical trials
Kakazu, V. A., Assis, M., Bacelar, A., Bezerra, A. G., Ciutti, G. L. R., Conway, S. G., Galduróz, J. C. F., Drager, L. F., Khoury, M. P., Leite, I. P. A., et al. (2024) · npj Biological Timing and Sleep · doi:10.1038/s44323-024-00014-0 · Cited by 6
“Regarding pharmacological interventions, thisincludesthedevelopmentandapprovalofnewdrugclasses,suchasdual orexinreceptorantagonists(DORAs) 11 – 13 .”
InfluentialSelf-citationKakazu, V. A., Assis, M., Bacelar, A., Bezerra, A. G., Ciutti, G. L. R., Conway, S. G., Galduróz, J. C. F., Drager, L. F., Khoury, M. P., Leite, I. P. A., et al. (2025) · Frontiers in Neurology · doi:10.3389/fneur.2025.1600767 · Cited by 5
Self-citationCarvalho, F., Tonon, A. C., Hidalgo, M. P., Martins Costa, M., & Mengue, S. S. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1405838 · Cited by 4
Chi, J.-Y., Zhu, R.-X., Cheng Ann, C. H. E. N., Xu, R.-L., Lyu, C.-Z., Yao, J.-X., Fu, M.-Q., Wang, D., & Du, G.-S. (2025) · Journal of Chinese Integrative Medicine · doi:10.1016/j.joim.2025.10.006 · Cited by 3
Metadata
- Authors
- Drager, L. F., Assis, M., Bacelar, A. F. R., Poyares, D. L. R., Conway, S. G., Pires, G. N., de Azevedo, A. P., Carissimi, A., Eckeli, A. L., Pentagna, Á., Almeida, C. M. O., Franco, C. M. R., Sobreira, E. S. T., Stelzer, F. G., Mendes, G. M., Minhoto, G. R., Linares, I. M. P., Sousa, K. M. M., Gitaí, L. L. G., Sukys-Claudino, L., Sobreira-Neto, M. A., Zanini, M. A., Margis, R., & Martinez, S. C. G.
- Affiliations
- Universidade de São Paulo (BR)
- Associação Brasileira do Sono, São Paulo, SP, Brazil.
- Departamento de Psicobiologia, Universidade Federal de São Paulo, São Paulo, Brazil.
- Instituto do Sono (BR)
- Instituto de Psiquiatria (IPq), Universidade de São Paulo, São Paulo, SP, Brazil.
- Faculdade Dom Bosco, Porto Alegre, RS, Brazil.
- Departamento de Neurociências e Ciências do Comportamento, Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo, Ribeirão Preto, SP, Brazil.
- Universidade do Estado do Amazonas (BR)
- Universidade Federal de Pernambuco (BR)
- Universidade Federal do Ceará (BR)
- Instituto de Especialidades e Sono, Goiânia, GO, Brazil.
- Pontifícia Universidade Católica do Paraná (BR)
- Universidade Federal de São Paulo (BR)
- Faculdade de Medicina, Universidade Federal de Alagoas, AL, Brazil.
- Universidade Federal de Santa Catarina (BR)
- Instituto de Assistência Médica ao Servidor Público Estadual (IAMPSE), São Paulo, SP, Brazil.
- Private clinic, Porto Alegre, RS, Brazil.
- Universidade Estadual de Campinas (UNICAMP) (BR)
- Corresponding author
- Drager, Luciano Ferreira
- ORCID
- Drager, Luciano Ferreira
- Assis, Márcia
- Bacelar, Andrea Frota Rego
- Poyares, Dalva Lucia Rollemberg
- Conway, Silvia Gonçalves
- Pires, Gabriel Natan
- de Azevedo, Alexandre Pinto
- Carissimi, Alicia
- Eckeli, Allan Luiz
- Pentagna, Álvaro
- Almeida, Carlos Maurício Oliveira
- Franco, Clélia Maria Ribeiro
- Sobreira, Emmanuelle Silva Tavares
- Stelzer, Fernando Gustavo
- Mendes, Giuliana Macedo
- Minhoto, Gisele Richter
- Linares, Ila Marques Porto
- Sousa, Ksdy Maiara Moura
- Gitaí, Livia Leite Góes
- Sukys-Claudino, Lucia
- Sobreira-Neto, Manoel Alves
- Zanini, Marcio Andrei
- Margis, Regina
- Martinez, Sandra Cristina Gonçalves
- Venue
- Sleep Science
- Publisher
- Georg Thieme Verlag KG
- Published
- 2023-10
- Volume
- 16
- Issue
- S 02
- Pages
- 507-549
- ISSN
- 1984-0063 (ISSN-L)
- 1984-0659
- PMC
- PMC10869237
- OpenAlex
- W4388892302
- Cited by
- 25
- References
- 268
- Citations by year
- 2026: 8 · 2025: 10 · 2024: 7
- FWCI
- 1.06
- Type
- journal article
- Language
- en
- Open access
- diamond
- doi.org
- Licence
- Locations
- Sleep Science (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Topics
- Social Sciences › Psychology › Experimental and Cognitive Psychology › Sleep and related disorders
- Health Sciences › Medicine › Physiology (medical) › Obstructive Sleep Apnea Research
- Social Sciences › Psychology › Experimental and Cognitive Psychology › Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
- Keywords
- chronic insomnia, insomnia diagnosis, insomnia treatment, adults, sleep medicine
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.